SGK1: a novel prognostic marker and potential drug target in medulloblastoma

被引：0
|
作者：
Pleier, S. [1 ,2 ]
Sturm, D. [1 ]
Remke, M. [1 ,2 ]
Witt, H. [1 ,2 ]
Goidts, V [1 ,2 ]
Reifenberger, G. [3 ]
Felsberg, J. [3 ]
Kulozik, A. E. [2 ]
Korshunov, A. [4 ]
Lichter, P. [1 ]
Pfister, S. M. [1 ,2 ]
机构：
[1] German Canc Res Ctr Heidelberg, Div Mol Genet, Heidelberg, Germany
[2] Univ Heidelberg Hosp, Dept Pediat Oncol Hematol & Immunol, Heidelberg, Germany
[3] Univ Dusseldorf, Dept Neuropathol, D-4000 Dusseldorf, Germany
[4] Univ Heidelberg Hosp, Dept Neuropathol, Heidelberg, Germany
来源：
KLINISCHE PADIATRIE | 2011年 / 223卷 / 03期
关键词：
D O I：
10.1055/s-0031-1277081
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
20
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [1] SGK1 IS A PROGNOSTIC MARKER AND NOVEL THERAPEUTIC TARGET IN MEDULLOBLASTOMA
    Sturm, D.
    Pleier, S.
    Remke, M.
    Witt, H.
    Reifenberger, G.
    Felsberg, J.
    Kulozik, A. E.
    Witt, O.
    Korshunov, A.
    Lichter, P.
    Pfister, S.
    NEURO-ONCOLOGY, 2010, 12 (06) : II56 - II57
  • [2] SGK1-a novel prognostic marker & potential drug target in medulloblastoma
    Pleier, S.
    Sturm, D.
    Remke, M.
    Witt, H.
    Goidts, V
    Reifenberger, G.
    Felsberg, J.
    Kulozik, A.
    Korshunov, A.
    Lichter, P.
    Pfister, S.
    KLINISCHE PADIATRIE, 2010, 222 (03): : 221 - 221
  • [3] Role of SGK1 as novel prognostic marker in medulloblastoma
    Pleier, S.
    Sturm, D.
    Remke, M.
    Witt, H.
    Goidts, V
    Reifenberger, G.
    Felsberg, J.
    Kulozik, A. E.
    Korshunov, A.
    Lichter, P.
    Pfister, S. M.
    KLINISCHE PADIATRIE, 2010, 222 (06): : 416 - 416
  • [4] IDENTIFICATION OF SGK1 AS A NOVEL PROGNOSTIC MARKER FOR DISEASE OUTCOME IN MEDULLOBLASTOMA
    Sturm, Dominik
    Remke, Marc
    Pleier, Sabrina
    Witt, Hendrik
    Reifenberger, Guido
    Felsberg, Joerg
    Kulozik, Andreas E.
    Korshunov, Andrey
    Lichter, Peter
    Pfister, Stefan
    NEURO-ONCOLOGY, 2009, 11 (05) : 651 - 652
  • [5] A NOVEL PROGNOSTIC MARKER AND POTENTIAL DRUG TARGET IN MEDULLOBLASTOMA
    Pleier, Sabrina
    Sturm, Dominik
    Remke, Marc
    Witt, Hendrik
    Rosenstiel-Goidts, Violaine
    Reifenberger, Guido
    Felsberg, Joerg
    Kulozik, Andreas
    Korshunov, Andrey
    Lichter, Peter
    Pfister, Stefan M.
    NEURO-ONCOLOGY, 2011, 13 : I14 - I15
  • [6] Identification of SGK1 as a novel predictive marker for treatment response in medulloblastoma
    Sturm, D.
    Remke, M.
    Pleier, S.
    Witt, H.
    Reifenberger, G.
    Felsberg, J.
    Kulozik, A.
    Korshunov, A.
    Lichter, P.
    Pfister, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] SGK1 in Cancer: Biomarker and Drug Target
    Cicenas, Jonas
    Meskinyte-Kausiliene, Edita
    Jukna, Vigilijus
    Rimkus, Arnas
    Simkus, Jokubas
    Soderholm, Diana
    CANCERS, 2022, 14 (10)
  • [8] Functional characterization of SGK1 in medulloblastoma biology
    Pleier, S.
    Sturm, D.
    Remke, M.
    Witt, H.
    Goidts, V
    Reifenberger, G.
    Felsberg, J.
    Kulozik, A.
    Korshunov, A.
    Lichter, P.
    Pfister, S.
    KLINISCHE PADIATRIE, 2009, 221 (03): : 204 - 205
  • [9] SGK1 expression predicts treatment response in paediatric medulloblastoma
    Sturm, D.
    Remke, M.
    Pleier, S.
    Witt, H.
    Reifenberger, G.
    Felsberg, J.
    Kulozik, A.
    Korshunov, A.
    Lichter, P.
    Pfister, S.
    KLINISCHE PADIATRIE, 2009, 221 (03): : 208 - 209
  • [10] Identification of SGK1 as a potential therapeutic target in castrate resistance prostate cancer
    Alsamraae, Massar I.
    McClurg, Urzsula
    Robson, Craig N.
    McCracken, Stuart
    CANCER RESEARCH, 2017, 77
12345